Yahoo! Finance: Mays Cancer Center led studies of innovative breast cancer drug that recently gained FDA approval

Virginia Kaklamani, MD, director, Breast Oncology Program, Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, and Dr. Patrick Sung, DPhil, interim executive director of Mays Cancer Center, Biochemistry and Structural Biology, are quoted in this story.


Read More

Share This Article!